| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.39 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |